A clinical trial to study the effects of two drugs,vati of rasanjan,laksha and aja ksheera and tablet progesterone in patients with heavy menstrual bleeding
Phase 2
Completed
- Conditions
- Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
- Registration Number
- CTRI/2023/04/051900
- Lead Sponsor
- Tilak Ayurved Mahavidyalaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
1 age group- 25-50 years
2 Increased number of bleeding days i.e more than 7days
3 Quantitave increase in menstrual blood i.e more than 80ml or more than 3 pads per day
4 Decreased intermenstrual period i.e lessthan 21 days
5 Fibroid uterus
Exclusion Criteria
1 Traumatic bleeding
2 Post-menopausal bleeding
3 Cervical, uterine, ovarianneoplasm
4 Coagulopathy
5 Endometriosis
6 Bleeding through gravid uterus
7 Cervical polyp
8 Cervical erosion
9 Hyertensive Disorders, DM, Bleeding disorders, Cardiac diseases
10 Severe anemia( Hb < 8gm%)
11 HIV,HbsAg,VDRL,HPV positive
12 Congenital anomalies of genital tract
13 Patient requiring emergency management
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 To assess decrease in number of menstrual bleeding days <br/ ><br>2 To assess quantitave decrease in menstrual bleeding <br/ ><br>3 To assess relief in Katishool(lower abdominal pain) <br/ ><br>4 Artavgrahitatwa(consistency presence of clots in menstrual blood)Timepoint: 3 months
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil